
Aulos Bioscience to Share Updated Phase 2 Imneskibart (AU-007) Data in Melanoma & NSCLC at SITC 2025
Aulos Bioscience to Present Updated Phase 2 Data for Imneskibart (AU-007) in CPI-Refractory Melanoma and NSCLC at SITC 40th Annual Meeting Aulos Bioscience, a pioneering immuno-oncology company dedicated to transforming…













